EDGAR Filing Documents for 0001144204-13-054331

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001144204-13-054331

Filing Date

2013-10-08

Accepted

2013-10-07 20:59:18

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-1/A	v356877_s1a.htm	S-1/A	808137
2		v356877_ex1-1.htm	EX-1.1	259910
3	EXHIBIT 5.1	v356877_ex5-1.htm	EX-5.1	11211
4	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	v356877_ex23-1.htm	EX-23.1	3092
5	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	v356877_ex23-2.htm	EX-23.2	2777
6	GRAPHIC	line.gif	GRAPHIC	43
7	GRAPHIC	spacer.gif	GRAPHIC	43
8	GRAPHIC	logo_intercept.jpg	GRAPHIC	4771
9	GRAPHIC	v356002_chrt-org.jpg	GRAPHIC	35919
10	GRAPHIC	tlogo.jpg	GRAPHIC	6449
	Complete submission text file	0001144204-13-054331.txt		1151852

Mailing Address 18 Desbrosses Street New York NY 10013

Business Address 18 Desbrosses Street NEW YORK NY 10013 646-747-1000

INTERCEPT PHARMACEUTICALS INC (Filer) CIK: 0001270073 (see all company filings)